JP2010011901A - Mixed injection member - Google Patents

Mixed injection member Download PDF

Info

Publication number
JP2010011901A
JP2010011901A JP2008172058A JP2008172058A JP2010011901A JP 2010011901 A JP2010011901 A JP 2010011901A JP 2008172058 A JP2008172058 A JP 2008172058A JP 2008172058 A JP2008172058 A JP 2008172058A JP 2010011901 A JP2010011901 A JP 2010011901A
Authority
JP
Japan
Prior art keywords
blood
blood circuit
tube
injection member
mixed injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008172058A
Other languages
Japanese (ja)
Other versions
JP5255344B2 (en
Inventor
Kazuhide Ono
和秀 小野
Katsumi Iso
勝美 五十右
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nikkiso Co Ltd
Original Assignee
Nikkiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikkiso Co Ltd filed Critical Nikkiso Co Ltd
Priority to JP2008172058A priority Critical patent/JP5255344B2/en
Publication of JP2010011901A publication Critical patent/JP2010011901A/en
Application granted granted Critical
Publication of JP5255344B2 publication Critical patent/JP5255344B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a mixed injection member to be connected to a blood circuit and capable of sufficiently suppressing disadvantage that a blood clot is formed in its inside. <P>SOLUTION: This mixed injection member 15 is provided with a communication passageway 20 communicated with the upstream section and the downstream section of the blood circuit 1 and allowing the passing of blood, and an insertion section 22 at the inner wall 20a of the communication passageway 20. An insertion tube is inserted into the insertion section 22 to communicate the communication passageway 20 with an insertion tube. The whole circumference of the inner wall 20a of the communication passageway 20 is formed flush with the inner circumferential face of the blood circuit 1 into a continuous face with no level difference. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

本発明は、血液回路の上流部と下流部とを接続し、血液回路中に薬液などを注入したり、あるいは血液回路中の血液を採取したりするための挿通部を設けた混注部材に関する。   The present invention relates to a co-infusion member provided with an insertion part for connecting an upstream part and a downstream part of a blood circuit and injecting a drug solution into the blood circuit or collecting blood in the blood circuit.

人工透析治療などに用いられる血液回路は、当該血液回路の上流部と下流部とを接続する混注部材(所謂アクセスポート)を当該血液回路の途中に備え、該混注部材の一部分にゴム製の栓体からなる穿脱部(挿通部)を設けている。そして、該穿脱部にシリンジの穿刺管(挿通管)を差し入れてシリンジと血液回路とを連通し、この連通状態でシリンジ内の薬液を穿刺管から血液回路中へ注入したり、あるいは血液回路中の血液を採取したりできるように構成されている。さらに、混注部材の内部のうち穿脱部を臨ませた箇所には、区画壁を穿脱部側へ凹ませて血液回路内の流路の断面積よりも広い断面積の空間部を形成し、穿刺管を空間部へ深く刺し込んで安定した状態で血液回路と連通できるように構成されている。   A blood circuit used for artificial dialysis treatment or the like includes a mixed injection member (so-called access port) that connects an upstream portion and a downstream portion of the blood circuit in the middle of the blood circuit, and a rubber stopper is provided in a part of the mixed injection member. A penetration part (insertion part) made of the body is provided. Then, a puncture tube (insertion tube) of a syringe is inserted into the piercing portion to communicate the syringe and the blood circuit, and in this communication state, the drug solution in the syringe is injected from the puncture tube into the blood circuit, or the blood circuit It is configured to collect blood inside. Furthermore, a space portion having a cross-sectional area wider than the cross-sectional area of the flow path in the blood circuit is formed by denting the partition wall toward the perforation portion side in the portion of the mixed injection member facing the penetration portion. The puncture tube is deeply inserted into the space and is configured to communicate with the blood circuit in a stable state.

しかしながら、この空間部のうち穿脱部の近傍、すなわち穿脱部側へ凹ませて形成された部分では血液が滞留したり空気が残留したりし易く、この結果、血液が凝固して血栓を形成し易い。この血栓は、混注部材から脱落して血液回路を途中(具体的にはドリップチャンバー内のメッシュ(フィルター))で閉塞させる虞がある。また、穿刺管から採血しようとする場合には、血栓が穿刺管を詰まらせて採血を行い難くなる虞がある。   However, blood is likely to stay or air remains in the vicinity of the piercing portion, that is, in the portion formed to be recessed toward the piercing portion, and as a result, blood clots and clots are formed. Easy to form. The thrombus may drop from the mixed injection member and block the blood circuit in the middle (specifically, a mesh (filter) in the drip chamber). In addition, when blood is to be collected from the puncture tube, there is a risk that a blood clot may clog the puncture tube, making it difficult to collect blood.

そこで、空間部の底部を血液回路の流路の底部よりも高くしたり(特許文献1参照)、空間部の区画壁のうち、穿脱部に対向する位置から穿脱部へ向けて隆起部を隆起したり(特許文献2参照)して、血栓の形成を阻止しようとする混注部材が提案されている。空間部の底部を低くした混注部材は、血液や空気が滞留し得る窪みが形成されることを避けて、血栓が発生する不都合をなくそうとしている。また、隆起部を備えた混注部材は、隆起部に血流を衝突させることで穿脱部の近傍にも血液が流れるようにして、血液が穿脱部の近傍で滞留する不都合、ひいては血栓が形成される不都合をなくそうとしている。
特許第3747912号公報 特開2006−129884号公報
Therefore, the bottom portion of the space portion is made higher than the bottom portion of the flow path of the blood circuit (see Patent Document 1), or the protruding portion from the position facing the piercing portion of the partition wall of the space portion toward the piercing portion. (See Patent Document 2), a mixed injection member that attempts to prevent thrombus formation has been proposed. The mixed injection member having a lower bottom of the space portion avoids the formation of a depression in which blood or air can stay, and eliminates the inconvenience of generating a thrombus. In addition, the mixed injection member provided with the bulging portion causes blood to flow also in the vicinity of the piercing portion by colliding the blood flow with the bulging portion, and the inconvenience that blood stays in the vicinity of the piercing portion, and thus thrombus It tries to eliminate the inconvenience that is formed.
Japanese Patent No. 3747912 JP 2006-129984 A

ところが、上記各特許文献に記載のものは、空間部と血液回路の流路との接続箇所や空間部内に段差を形成しており、この段差部分に血液や空気が滞留する可能性がある。このため、血栓の形成を十分に抑えることができず、改善の余地を残している。   However, the devices described in each of the above-mentioned patent documents form a step in the connection portion between the space portion and the flow path of the blood circuit or in the space portion, and blood or air may stay in the step portion. For this reason, the formation of thrombus cannot be sufficiently suppressed, leaving room for improvement.

本発明は、上記した事情に鑑みてなされたものであり、その目的は、内部に血栓が形成される不都合を十分に抑えることができる混注部材を提供しようとするものである。   The present invention has been made in view of the above-described circumstances, and an object thereof is to provide a co-infusion member that can sufficiently suppress the inconvenience that a thrombus is formed inside.

本発明は、上記目的を達成するために提案されたものであり、請求項1に記載のものは、血液回路の上流部および下流部に連通して血液が通過可能な連通路を備え、該連通路の内壁に挿通部を設け、該挿通部に挿通管を挿通して連通路と挿通管とを連通可能な混注部材であって、
前記連通路の内壁全周を、血液回路の内周面と段差のない連続面上で揃う状態に形成したことを特徴とする混注部材である。
The present invention has been proposed in order to achieve the above-mentioned object, and the device according to claim 1 includes a communication passage that allows blood to pass through the upstream portion and the downstream portion of the blood circuit. A mixed injection member that is provided with an insertion portion on the inner wall of the communication passage, allows the insertion passage to pass through the insertion tube, and allows the communication passage and the insertion tube to communicate with each other.
The co-infusion member is characterized in that the entire inner wall of the communication passage is formed on a continuous surface having no step with the inner peripheral surface of the blood circuit.

請求項2に記載のものは、前記挿通部のうち連通路に露出する露出面を、血液回路の内周面と段差のない連続面上で揃う状態に形成したことを特徴とする請求項1に記載の混注部材である。   According to a second aspect of the present invention, the exposed surface exposed to the communication path in the insertion portion is formed so as to be aligned on a continuous surface having no step with the inner peripheral surface of the blood circuit. It is a mixed injection member as described in above.

請求項3に記載のものは、前記挿通部は、弾性部材で形成された栓体を備えたことを特徴とする請求項1または請求項2に記載の混注部材である。   According to a third aspect of the present invention, in the mixed injection member according to the first or second aspect, the insertion portion includes a plug formed of an elastic member.

本発明によれば、以下のような優れた効果を奏する。
すなわち、血液回路の上流部および下流部に連通して血液が通過可能な連通路を備え、該連通路の内壁に挿通部を設け、該挿通部に挿通管を挿通して連通路と挿通管とを連通可能な混注部材であって、連通路の内壁全周を、血液回路の内周面と段差のない連続面上で揃う状態に形成したので、血液や生理食塩水を連通路内へスムーズに誘導することができ、血液や生理食塩水の流れに澱みが生じることがない。したがって、混注部材内に血液の滞留や空気の残留が生じることを防ぐことができ、滞留血液や残留空気の影響で血栓が形成される不都合を十分に抑えることができる。
According to the present invention, the following excellent effects can be obtained.
That is, a communication passage that is communicated with the upstream portion and the downstream portion of the blood circuit and through which blood can pass is provided. The entire inner wall of the communication passage is formed on a continuous surface that has no step with the inner peripheral surface of the blood circuit, so blood and physiological saline can be introduced into the communication passage. It can be guided smoothly and no stagnation occurs in the blood or saline flow. Therefore, it is possible to prevent the retention of blood and the remaining of air in the mixed injection member, and it is possible to sufficiently suppress the disadvantage that a thrombus is formed due to the influence of the staying blood and the remaining air.

また、挿通部のうち連通路に露出する露出面を、血液回路の内周面と段差のない連続面上で揃う状態に形成したので、露出面上や露出面の周縁で血液の滞留や空気の残留が生じることを防ぐことができ、滞留血液や残留空気の影響で血栓が形成される不都合を一層確実に抑えることができる。   In addition, the exposed surface exposed to the communication path in the insertion portion is formed so as to be aligned with the inner peripheral surface of the blood circuit on a continuous surface without a step, so that blood retention and air are formed on the exposed surface and the periphery of the exposed surface. Can be prevented, and the inconvenience that thrombus is formed by the influence of the staying blood and the remaining air can be more reliably suppressed.

以下、本発明の最良の実施形態を図面に基づいて説明する。
図1は血液回路1の概略図である。人工透析治療等のように体外循環による血液浄化療法に使用する血液回路1は、図1に示すように、穿刺針2と穿刺針3とを結ぶチューブ4からなる第1経路Aの途中に、血液ポンプ5が当接される可撓性チューブ6と、ドリップチャンバー7,8、及び血液浄化器9が配設され、T管10により枝分かれした第2経路Bの途中に輸液チャンバー11が配設されている。また、第2経路Bの先端は、輸液容器12に接続されており、プライミング時に第2経路Bを介して第1経路Aに生理食塩水を供給するとともに、場合によっては血液が第1経路Aを循環中、輸液剤の注入又は輸血を行い得る構成とされている。なお、この血液回路1では、第1経路Aの大部分を構成しているチューブ4とドリップチャンバー7,8を、外部から内部の血液通過を透視可能な内部透視部として機能させている。
DESCRIPTION OF EXEMPLARY EMBODIMENTS Hereinafter, the best embodiment of the invention will be described with reference to the drawings.
FIG. 1 is a schematic diagram of a blood circuit 1. As shown in FIG. 1, a blood circuit 1 used for blood purification therapy by extracorporeal circulation such as an artificial dialysis treatment is in the middle of a first path A composed of a tube 4 connecting a puncture needle 2 and a puncture needle 3. A flexible tube 6 with which the blood pump 5 abuts, drip chambers 7 and 8 and a blood purifier 9 are disposed, and an infusion chamber 11 is disposed in the middle of the second path B branched by the T tube 10. Has been. In addition, the tip of the second path B is connected to the infusion container 12 and supplies physiological saline to the first path A via the second path B at the time of priming. In the circulation, an infusion solution or blood transfusion can be performed. In the blood circuit 1, the tube 4 and the drip chambers 7 and 8 constituting most of the first path A function as an internal see-through unit that can see through the internal blood from the outside.

そして、血液回路1の途中部分、具体的には、チューブ4の途中部分には、混注部材15を備えている。混注部材15は、図2に示すように、長尺なハウジング16を備え、該ハウジング16の一端部(図2(a)〜(d)中、左端部)には、断面円形状の上流接続空間部17を形成し、該上流接続空間部17に血液回路1の上流部、詳しくは混注部材15よりも上流側に位置するチューブ4の端部を嵌合可能としている。また、ハウジング16の他端部(図2(a)〜(d)中、右端部)には、断面円形状の下流接続空間部18を上流接続空間部17の中心軸と下流接続空間部18の中心軸とが同一直線上に位置する状態で形成し、該下流接続空間部18に血液回路1の下流部、詳しくは混注部材15よりも下流側に位置するチューブ4の端部を嵌合可能としている。そして、図2(d)に示すように、上流接続空間部17と下流接続空間部18との間には、ハウジング16の長手方向に沿って延在する断面円形状の連通路20を形成し、該連通路20を上流接続空間部17および下流接続空間部18へ連通している。したがって、混注部材15は、連通路20を血液回路1の上流部および下流部へ連通し、連通路20内に血液を通過可能としている。なお、ハウジング16は、ポリカーボネートや硬質塩化ビニル等のプラスチック材料にて形成されている。   A mixed injection member 15 is provided in the middle part of the blood circuit 1, specifically, in the middle part of the tube 4. As shown in FIG. 2, the mixed injection member 15 includes a long housing 16. One end of the housing 16 (the left end in FIGS. 2A to 2D) has an upstream connection with a circular cross section. A space portion 17 is formed, and the upstream connection space portion 17 can be fitted with an upstream portion of the blood circuit 1, specifically, an end portion of the tube 4 positioned on the upstream side of the co-infusion member 15. Further, at the other end of the housing 16 (the right end in FIGS. 2A to 2D), the downstream connection space 18 having a circular cross section is connected to the central axis of the upstream connection space 17 and the downstream connection space 18. And the end of the tube 4 located downstream of the co-infusion member 15 is fitted into the downstream connection space 18 in detail. It is possible. As shown in FIG. 2D, a communication passage 20 having a circular cross section extending along the longitudinal direction of the housing 16 is formed between the upstream connection space portion 17 and the downstream connection space portion 18. The communication path 20 communicates with the upstream connection space 17 and the downstream connection space 18. Therefore, the mixed injection member 15 communicates the communication path 20 with the upstream portion and the downstream portion of the blood circuit 1 so that blood can pass through the communication path 20. The housing 16 is made of a plastic material such as polycarbonate or hard vinyl chloride.

また、連通路20を両端から中央部へ向かうにつれて僅かではあるが次第に縮径し、連通路20の内壁20aをなだらかで段差がない円筒状曲面で形成している。そして、連通路20の両端をチューブ4(血液回路1)と同じ内径寸法に設定するとともに、連通路20の中心軸をチューブ4の中心軸の延長線上(または上流接続空間部17および下流接続空間部18の中心軸の延長線上)に設定して、円筒状曲面で形成された連通路20の内壁20aの全周をチューブ4の内周面と段差のない連続面上(言い換えると同一曲面上)で揃う状態に形成している。   In addition, the diameter of the communication path 20 gradually decreases as it goes from both ends toward the center, and the inner wall 20a of the communication path 20 is formed with a cylindrical curved surface having no gentle steps. Then, both ends of the communication path 20 are set to have the same inner diameter as the tube 4 (blood circuit 1), and the central axis of the communication path 20 is on an extension line of the central axis of the tube 4 (or the upstream connection space portion 17 and the downstream connection space). The entire circumference of the inner wall 20a of the communication passage 20 formed by a cylindrical curved surface is set on a continuous surface having no step with the inner circumferential surface of the tube 4 (in other words, on the same curved surface). ).

さらに、連通路20の内壁20aの一部には、薬剤を注入するための注入管や、採血するための採血管などの挿通管(図示せず)を挿脱可能な挿通部22を設け、該挿通部22を介して血液回路1中(詳しくは血液回路1内を流れる血液中)に薬液などを注入したり、あるいは血液回路1から血液を採取したりできるように構成されている。具体的には、連通路20の内壁20aのうち上流接続空間部17または下流接続空間部18が接続される箇所とは異なる箇所を開放し、該開放口に挿通部22を設けている。挿通部22は、図2(d),(e)に示すように、内壁20aの側部に栓体(所謂ゴムボタン)24を配置して開放口を液密状態で閉塞し、栓体24のうち連通路20に露出する露出面24aを、チューブ4(血液回路1)の内周面および連通路20の内壁20aと段差のない連続面上(言い換えると同一曲面上)で揃う状態に形成し、栓体24が連通路20の内壁20aから突出したり凹んだりした状態で配置されることを避けている。なお、栓体24は、シリコーンゴムやイソプレンゴム等の弾性材料で形成されている。   Furthermore, a part of the inner wall 20a of the communication path 20 is provided with an insertion portion 22 through which an insertion tube (not shown) such as an injection tube for injecting a drug or a blood collection tube for blood collection can be inserted and removed, It is configured such that a drug solution or the like can be injected into the blood circuit 1 (specifically, blood flowing in the blood circuit 1) or blood can be collected from the blood circuit 1 via the insertion portion 22. Specifically, a portion of the inner wall 20a of the communication passage 20 that is different from the portion to which the upstream connection space portion 17 or the downstream connection space portion 18 is connected is opened, and the insertion portion 22 is provided at the opening. As shown in FIGS. 2 (d) and 2 (e), the insertion portion 22 is provided with a plug (so-called rubber button) 24 on the side of the inner wall 20 a to close the opening in a liquid-tight state. The exposed surface 24a exposed to the communication path 20 is formed so as to be aligned on the inner peripheral surface of the tube 4 (blood circuit 1) and the inner wall 20a of the communication path 20 on a continuous surface (in other words, on the same curved surface). However, the plug body 24 is avoided from being disposed in a state of protruding or recessed from the inner wall 20a of the communication path 20. The plug 24 is made of an elastic material such as silicone rubber or isoprene rubber.

また、栓体24の外側(当該栓体24を挟んで連通路20とは反対側)に位置する縁部をカバー25で覆い、該カバー25をハウジング16に止着して栓体24が脱落することを阻止し、カバー25の中央部分には貫通口25aを挿通管が十分に通過可能な程度の大きさで開設し、該貫通口25aから栓体24を外方(言い換えると連通路20とは反対方向)へ露出している。さらに、栓体24のうち露出面24aから貫通口25aに亘る箇所にはスリット(挿通口)26を形成し、挿通管をスリット26へ挿通していない常態ではスリット26が栓体24の弾性復元力により液密状態で閉成し、挿通管を栓体24の弾性復元力に抗してスリット26へ押し込むと、スリット26が開いて挿通管を通すとともに、スリット26の縁部と挿通管の外周面とが液密状態で密着するように構成されている。そして、挿通管の開放端を連通路20へ臨ませれば、挿通管を連通路20へ連通することができ、ひいては挿通管を血液回路1の内部へ連通できるように構成されている。なお、カバー25は、ポリプロピレンやポリカーボネート、硬質塩化ビニル等のプラスチック材料にて形成されている。   Further, an edge located outside the plug body 24 (on the opposite side of the communication path 20 across the plug body 24) is covered with a cover 25, and the cover 25 is fixed to the housing 16 so that the plug body 24 falls off. In the central portion of the cover 25, a through-hole 25a is opened with a size that allows the insertion tube to sufficiently pass therethrough, and the plug 24 is opened outwardly (in other words, the communication passage 20 from the through-hole 25a). It is exposed in the opposite direction. Furthermore, a slit (insertion port) 26 is formed in a portion of the plug body 24 extending from the exposed surface 24 a to the through hole 25 a, and the slit 26 is elastically restored to the plug body 24 in a normal state where the insertion tube is not inserted into the slit 26. When the insertion tube is pushed into the slit 26 against the elastic restoring force of the plug 24, the slit 26 is opened and the insertion tube is passed, and the edge of the slit 26 and the insertion tube are closed. It is comprised so that it may closely_contact | adhere with an outer peripheral surface in a liquid-tight state. If the open end of the insertion tube faces the communication passage 20, the insertion tube can be connected to the communication passage 20, and thus the insertion tube can be connected to the inside of the blood circuit 1. The cover 25 is made of a plastic material such as polypropylene, polycarbonate, or hard vinyl chloride.

このような構成の混注部材15を血液回路1に備え、生理食塩水を血液回路1の上流側から流下させてプライミング作業を行うと、生理食塩水は、チューブ4から混注部材15の連通路20へ流入する。このとき、連通路20の内壁20aの全周をチューブ4(血液回路1)の内周面と段差のない連続面上で揃う状態に形成しているので、生理食塩水をチューブ4から連通路20内へスムーズに誘導することができ、生理食塩水の流れに澱みが生じることがない。したがって、混注部材15内の空気を生理食塩水により押し流して、空気が残留すること、ひいては透析治療時に残留空気の影響で血栓が形成される不都合を十分に抑えることができる。また、挿通部22(栓体24)の露出面24aをも血液回路1の内周面と段差のない連続面上で揃う状態に形成しているので、露出面24a上や露出面24aの周縁で空気の残留が生じることを防ぐことができ、残留空気の影響で血栓が形成される不都合を一層抑えることができる。そして、透析治療を行うスタッフは、空気が残留しているか否かの確認作業を頻繁に行ったり、混注部材15を軽く叩いて空気の残留を解消したりする必要がなくなり、透析治療の準備作業の負担を軽減し易い。さらに、混注部材15に衝撃を加えずに透析準備を行うことができ、混注部材15が破損する不都合、ひいては透析治療の開始が遅延する不都合を抑制することができる。   When the mixed injection member 15 having such a configuration is provided in the blood circuit 1 and a priming operation is performed by flowing physiological saline from the upstream side of the blood circuit 1, the physiological saline is communicated from the tube 4 to the communication path 20 of the mixed injection member 15. Flow into. At this time, since the entire circumference of the inner wall 20a of the communication path 20 is formed on a continuous surface having no step with the inner peripheral surface of the tube 4 (blood circuit 1), the physiological saline is communicated from the tube 4 to the communication path. 20 can be smoothly guided into the saline solution, and no stagnation occurs in the physiological saline flow. Therefore, it is possible to sufficiently suppress the inconvenience that air in the co-infusion member 15 is washed away with physiological saline and the air remains, and that thrombus is formed due to the residual air during dialysis treatment. Moreover, since the exposed surface 24a of the insertion part 22 (plug 24) is also formed on the continuous surface without a step with the inner peripheral surface of the blood circuit 1, the exposed surface 24a and the peripheral edge of the exposed surface 24a Therefore, it is possible to prevent the remaining of air from occurring, and it is possible to further suppress the disadvantage that a thrombus is formed due to the influence of the remaining air. The staff who performs dialysis treatment does not need to frequently check whether or not air remains, or lightly tap the mixed injection member 15 to eliminate the remaining air. It is easy to reduce the burden. Furthermore, dialysis preparation can be performed without applying an impact to the mixed injection member 15, and the inconvenience that the mixed injection member 15 is damaged and consequently the start of the dialysis treatment can be suppressed.

そして、透析治療を開始して血液を血液回路1の上流側から流下させると、血液は、チューブ4から混注部材15の連通路20へ流入する。このとき、連通路20の内壁20aの全周をチューブ4(血液回路1)の内周面と段差のない連続面上で揃う状態に形成しているので、血液をチューブ4から連通路20内へスムーズに誘導することができ、血液の流れに澱みが生じることがない。したがって、混注部材15内に血液が滞留することを防ぐことができ、滞留血液により血栓が形成される不都合を十分に抑えることができる。また、挿通部22(栓体24)の露出面24aをも血液回路1の内周面と段差のない連続面上で揃う状態に形成しているので、露出面24a上や露出面24aの周縁で血液が滞留することを防ぐことができ、滞留血液により血栓が形成される不都合を一層確実に抑えることができる。そして、混注部材15よりも下流側に配置されたドリップチャンバー8内のメッシュに血栓が詰まる虞をなくすことができ、安定した透析治療を行うことができる。また、採血時には、挿通部22を介して連通路20に連通した挿通管が血栓で詰まる虞がなく、採血を円滑に行うことができる。加えて、採血した血液に血栓が混ざる不都合を抑制することができ、採血した血液の検査データの信頼性を向上させることができる。   When the dialysis treatment is started and the blood is allowed to flow down from the upstream side of the blood circuit 1, the blood flows from the tube 4 into the communication path 20 of the mixed injection member 15. At this time, the entire circumference of the inner wall 20a of the communication path 20 is formed so as to be aligned with the inner peripheral surface of the tube 4 (blood circuit 1) on a continuous surface without a step, so that blood can be passed from the tube 4 to It can be smoothly guided to the bloodstream, and no stagnation occurs in the blood flow. Therefore, it is possible to prevent blood from staying in the mixed injection member 15, and to sufficiently suppress the inconvenience that a thrombus is formed by the staying blood. Moreover, since the exposed surface 24a of the insertion part 22 (plug 24) is also formed on the continuous surface without a step with the inner peripheral surface of the blood circuit 1, the exposed surface 24a and the peripheral edge of the exposed surface 24a Therefore, it is possible to prevent blood from staying, and it is possible to more reliably suppress the inconvenience that thrombus is formed by the staying blood. In addition, it is possible to eliminate the possibility of clogging the thrombus in the mesh in the drip chamber 8 arranged on the downstream side of the mixed injection member 15, and stable dialysis treatment can be performed. Moreover, at the time of blood collection, there is no possibility that the insertion tube communicated with the communication path 20 via the insertion portion 22 is clogged with thrombus, and blood collection can be performed smoothly. In addition, it is possible to suppress the inconvenience that blood clots are mixed with the collected blood and to improve the reliability of the test data of the collected blood.

また、連通路20の内壁20aの全周、挿通部22(栓体24)の露出面24a、血液回路1の内周面を段差のない連続面上で揃えるだけで血栓の発生を抑えることができる。したがって、従来の混注部材15の構成に特殊な部品を追加せずに血栓が発生し難い混注部材15を実現することができ、血栓が発生し難い混注部材15の製造コストが高くなったり、製造工程が複雑になったりすることを避けることができる。   In addition, thrombus generation can be suppressed by aligning the entire circumference of the inner wall 20a of the communication passage 20, the exposed surface 24a of the insertion portion 22 (plug 24), and the inner circumferential surface of the blood circuit 1 on a continuous surface having no steps. it can. Therefore, it is possible to realize the mixed injection member 15 in which thrombus is unlikely to occur without adding special parts to the configuration of the conventional mixed injection member 15, and the manufacturing cost of the mixed injection member 15 in which thrombus is unlikely to be generated is increased. The complexity of the process can be avoided.

さらに、連通路20の両端をチューブ4の内径に揃えるとともに、連通路20を両端から中央部へ向かうにつれて次第に縮径し、連通路20の中央部を栓体24の露出面24aの曲面に揃えているので、連通路20の端部の開口径の設定(大きさ)を変更したとしても、連通路20の内壁20aの勾配の設定を調整すれば、連通路20の中央部の開口径を異ならせる必要がない。したがって、様々な内径寸法のチューブ4に対応させる毎に、露出面24aの形状が異なる栓体24を準備する必要がない。これにより、栓体24を多種類の混注部材15の共通部品とすることができ、混注部材15の製造コストの削減を図ることができる。なお、チューブ4の内径寸法が連通路20の中央部の開口径よりも小さい場合には、連通路20を両端から中央部へ向かうにつれて次第に拡径して、連通路20の中央部を栓体24の露出面24aの曲面に揃えることが好適である。また、連通路20を両端から中央部へ向かうにつれて次第に縮径した場合には、連通路20の縮径部で内部を流れる流体の流速を大きくすることができる。したがって、プライミング作業時に、連通路20の内壁20aに気泡が付着していたとしても、流速が大きくなった生理食塩水によりこの気泡を内壁20aから剥がして押し流すことができる。   Further, both ends of the communication path 20 are aligned with the inner diameter of the tube 4, and the diameter of the communication path 20 is gradually reduced from both ends toward the central part, and the central part of the communication path 20 is aligned with the curved surface of the exposed surface 24 a of the plug body 24. Therefore, even if the setting (size) of the opening diameter of the end portion of the communication path 20 is changed, if the setting of the gradient of the inner wall 20a of the communication path 20 is adjusted, the opening diameter of the central portion of the communication path 20 is changed. There is no need to make them different. Therefore, it is not necessary to prepare a plug 24 having a different shape of the exposed surface 24a every time it is made to correspond to the tubes 4 having various inner diameters. Thereby, the plug 24 can be used as a common part for many kinds of mixed injection members 15, and the manufacturing cost of the mixed injection member 15 can be reduced. When the inner diameter dimension of the tube 4 is smaller than the opening diameter of the central portion of the communication passage 20, the diameter of the communication passage 20 is gradually increased from both ends toward the central portion, and the central portion of the communication passage 20 is plugged. It is preferable to align with the curved surface of the 24 exposed surfaces 24a. Further, when the diameter of the communication passage 20 is gradually reduced from both ends toward the central portion, the flow velocity of the fluid flowing through the inside at the reduced diameter portion of the communication passage 20 can be increased. Therefore, even if air bubbles are attached to the inner wall 20a of the communication path 20 during the priming operation, the air bubbles can be peeled off from the inner wall 20a by the physiological saline whose flow rate is increased.

ところで、上記実施形態では、栓体24の露出面24aを円弧状に形成して連通路20へ臨ませたが、本発明はこれに限定されない。例えば、図3に示す第2実施形態のように、栓体24の露出面24aを円筒状に形成して連通路20へ臨ませ、言い換えると、栓体24に連通路20の中央部分と同じ大きさの貫通孔を開設して円筒状の露出面24aを形成し、この露出面24aを連通路20の内周面および血液回路1の内周面と段差のない連続面上で揃う状態に形成してもよい。このような円筒状の露出面24aを備えた場合であっても、混注部材15内に血液の滞留や空気の残留が生じることを防ぐことができ、滞留血液や残留空気の影響で血栓が形成される不都合を十分に抑えることができる。また、混注部材15のカバー25に螺旋状突起25bを突設し、該螺旋状突起25bに挿通管の一部を係合すれば、スリット26に挿通された挿通管が脱落することを阻止できて好適である。   By the way, in the said embodiment, although the exposed surface 24a of the plug body 24 was formed in circular arc shape and faced the communicating path 20, this invention is not limited to this. For example, as in the second embodiment shown in FIG. 3, the exposed surface 24 a of the plug body 24 is formed in a cylindrical shape and faces the communication path 20, in other words, the plug body 24 is the same as the central portion of the communication path 20. A through-hole having a size is opened to form a cylindrical exposed surface 24a, and the exposed surface 24a is aligned with the inner peripheral surface of the communication path 20 and the inner peripheral surface of the blood circuit 1 on a continuous surface without a step. It may be formed. Even when such a cylindrical exposed surface 24a is provided, it is possible to prevent blood from staying and air from remaining in the co-infusion member 15, and a thrombus is formed under the influence of the staying blood and residual air. Can be sufficiently suppressed. Further, if the spiral projection 25b is provided on the cover 25 of the mixed injection member 15 and a part of the insertion tube is engaged with the spiral projection 25b, the insertion tube inserted into the slit 26 can be prevented from dropping off. It is preferable.

ところで、上記各実施形態では、スリット26に挿通管を挿通するように構成されたが、本発明はこれに限定されない。例えば、図4に示す第3実施形態のように、栓体24にスリット26を形成することを避けてもよい。そして、薬剤を注入するための注入針や、採血するための採血針などの穿刺管(図示せず)を栓体24へ穿刺して穿刺管の先端を連通路20へ臨ませ、穿刺管と連通路20とを連通できるようにしてもよい。   By the way, in each said embodiment, although comprised so that an insertion tube may be penetrated to the slit 26, this invention is not limited to this. For example, it may be avoided to form the slit 26 in the plug 24 as in the third embodiment shown in FIG. Then, a puncture tube (not shown) such as an injection needle for injecting a drug or a blood collection needle for collecting blood is punctured into the plug body 24 so that the tip of the puncture tube faces the communication path 20, and the puncture tube The communication path 20 may be communicated.

血液回路の概略図である。It is the schematic of a blood circuit. 第1実施形態における混注部材の説明図であり、(a)は斜視図、(b)は平面図、(c)は正面図、(d)は(b)のA−A断面図、(e)は(c)のB−B断面図である。It is explanatory drawing of the co-injection member in 1st Embodiment, (a) is a perspective view, (b) is a top view, (c) is a front view, (d) is AA sectional drawing of (b), (e ) Is a sectional view taken along line BB in FIG. 第2実施形態における混注部材の説明図であり、(a)は斜視図、(b)は平面図、(c)は正面図、(d)は(b)のC−C断面図、(e)は(c)のD−D断面図である。It is explanatory drawing of the co-injection member in 2nd Embodiment, (a) is a perspective view, (b) is a top view, (c) is a front view, (d) is CC sectional drawing of (b), (e ) Is a sectional view taken along the line DD of (c). 第3実施形態における混注部材の説明図であり、(a)は斜視図、(b)は平面図、(c)は正面図、(d)は(b)のE−E断面図、(e)は(c)のF−F断面図である。It is explanatory drawing of the co-injection member in 3rd Embodiment, (a) is a perspective view, (b) is a top view, (c) is a front view, (d) is EE sectional drawing of (b), (e ) Is a sectional view taken along line FF in FIG.

符号の説明Explanation of symbols

1 血液回路
2,3 穿刺針
4 チューブ
5 血液ポンプ
6 可撓性チューブ
7,8 ドリップチャンバー
9 血液浄化器
10 T管
11 輸液チャンバー
12 輸液容器
15 混注部材
16 ハウジング
17 上流接続空間部
18 下流接続空間部
20 連通路
20a 内壁
22 挿通部
24 栓体
24a 露出面
25 カバー
25a 貫通口
25b 螺旋状突起
26 スリット
DESCRIPTION OF SYMBOLS 1 Blood circuit 2,3 Puncture needle 4 Tube 5 Blood pump 6 Flexible tube 7,8 Drip chamber 9 Blood purifier 10 T tube 11 Infusion chamber 12 Infusion container 15 Mixed injection member 16 Housing 17 Upstream connection space 18 Downstream connection space Part 20 Communication path 20a Inner wall 22 Insertion part 24 Plug 24a Exposed surface 25 Cover 25a Through-hole 25b Helical projection 26 Slit

Claims (3)

血液回路の上流部および下流部に連通して血液が通過可能な連通路を備え、該連通路の内壁に挿通部を設け、該挿通部に挿通管を挿通して連通路と挿通管とを連通可能な混注部材であって、
前記連通路の内壁全周を、血液回路の内周面と段差のない連続面上で揃う状態に形成したことを特徴とする混注部材。
A communication path that communicates with the upstream portion and the downstream portion of the blood circuit and through which blood can pass is provided, an insertion portion is provided on the inner wall of the communication passage, and an insertion tube is inserted into the insertion portion to connect the communication passage and the insertion tube. A mixed injection member capable of communicating,
A co-infusion member characterized in that the entire inner wall of the communication passage is formed on a continuous surface having no step with the inner peripheral surface of the blood circuit.
前記挿通部のうち連通路に露出する露出面を、血液回路の内周面と段差のない連続面上で揃う状態に形成したことを特徴とする請求項1に記載の混注部材。   2. The co-infusion member according to claim 1, wherein an exposed surface exposed to the communication path in the insertion portion is formed so as to be aligned on a continuous surface having no step with the inner peripheral surface of the blood circuit. 前記挿通部は、弾性部材で形成された栓体を備えたことを特徴とする請求項1または請求項2に記載の混注部材。   The mixed injection member according to claim 1, wherein the insertion portion includes a stopper formed of an elastic member.
JP2008172058A 2008-07-01 2008-07-01 Mixed injection material Active JP5255344B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008172058A JP5255344B2 (en) 2008-07-01 2008-07-01 Mixed injection material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008172058A JP5255344B2 (en) 2008-07-01 2008-07-01 Mixed injection material

Publications (2)

Publication Number Publication Date
JP2010011901A true JP2010011901A (en) 2010-01-21
JP5255344B2 JP5255344B2 (en) 2013-08-07

Family

ID=41698654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008172058A Active JP5255344B2 (en) 2008-07-01 2008-07-01 Mixed injection material

Country Status (1)

Country Link
JP (1) JP5255344B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51135490U (en) * 1975-04-24 1976-11-01
JPS6431752U (en) * 1987-08-03 1989-02-27

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51135490U (en) * 1975-04-24 1976-11-01
JPS6431752U (en) * 1987-08-03 1989-02-27

Also Published As

Publication number Publication date
JP5255344B2 (en) 2013-08-07

Similar Documents

Publication Publication Date Title
JP3525431B2 (en) Medical injection port
JP4324973B2 (en) Mixed injection port
JP5952413B2 (en) connector
US10315022B2 (en) Co-injection member
JP6059338B2 (en) connector
JP2014014677A (en) Valved tip catheter
EP3266477B1 (en) Air trap chamber
JP5255344B2 (en) Mixed injection material
JP6741209B2 (en) Filter assembly
JP5818538B2 (en) Indwelling needle
JP5019242B1 (en) Medical infusion intravenous injection device
JP2005334280A (en) Transfusion tube and transfusion tube set
JP2001353215A (en) Clamping device for medical flexible tube
JP4066222B2 (en) Connector with automatic opening / closing valve and medical device using the same
JP5128200B2 (en) Mixed injection material
JP3958956B2 (en) Indwelling needle assembly
WO2022186352A1 (en) Air trap chamber
CN208756690U (en) Safety indwelling needle
JP3135582U (en) Drip chamber and blood circuit with drip chamber
WO2023127936A1 (en) Access port member and production method for same
JP4552639B2 (en) Medical connector
JP3118321U (en) Plastic needles and medical devices
JP6246306B2 (en) connector
JP2003260139A (en) Venous detention catheter
JP3646727B2 (en) Medical mixed injection port

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120821

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121019

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130402

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130419

R150 Certificate of patent or registration of utility model

Ref document number: 5255344

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160426

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250